MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit. [electronic resource]
Producer: 20150127Description: 1837-45 p. digitalISSN:- 1949-2553
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- DNA Mutational Analysis
- DNA, Neoplasm -- genetics
- Disease-Free Survival
- Esophageal Neoplasms -- drug therapy
- Esophagogastric Junction
- Female
- Gene Amplification
- Humans
- Male
- Middle Aged
- Mutation
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
- Stomach Neoplasms -- drug therapy
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.